79,333
Total Claims
$13.7M
Drug Cost
5,748
Beneficiaries
$2,385
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-54%
Cost per patient vs peers
$2,385 vs $5,138 avg
-26%
Brand preference vs peers
45.1% vs 61.4% avg
Brand vs Generic
55% generic
Brand: 35,801 claims · $12.1M
Generic: 43,521 claims · $1.6M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Budesonide/Formoterol Fumarate | 5,055 | $2.1M |
| Fluticasone/Umeclidin/Vilanter | 2,391 | $1.6M |
| Tiotropium Bromide | 2,137 | $1.2M |
| Tiotropium Bromide | 2,215 | $1.2M |
| Nintedanib Esylate | 70 | $897K |
| Budesonide/Formoterol Fumarate | 2,961 | $790K |
| Budesonide/Glycopyr/Formoterol | 981 | $660K |
| Albuterol Sulfate | 17,443 | $597K |
| Fluticasone/Vilanterol | 1,352 | $588K |
| Fluticasone Propion/Salmeterol | 2,541 | $492K |
| Fluticasone Propion/Salmeterol | 1,118 | $482K |
| Ipratropium Bromide | 803 | $395K |
| Ipratropium/Albuterol Sulfate | 592 | $298K |
| Fluticasone Propion/Salmeterol | 1,366 | $280K |
| Ipratropium Bromide | 6,388 | $252K |
Prescribing Profile
43
Unique Drugs
Patient Profile
75
Avg Age
64%
Female
2.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About